Cardiology

An analysis of more than 2k mother-child pairs indicates assessments of maternal cardiovascular health could shed light on the potential for poor cardiovascular health among their children at ages 10-14 years.

An analysis of nearly 150 patients with severe COVID-19 and increased troponin levels indicates more than half of those patients went on to develop infarction, myocarditis, ischemia, or a combination of the three.

Researchers find a significant benefit at day 28 when compared to a group taking a placebo.

Check out our latest case report from Brady Pregerson, MD, which features a man in his 70s who recently recovered from COVID-19. Can you determine the correct diagnosis?

The approval was based on data from the PARAGON-HF study.

Dr. Khan discusses some of the risk factors associated with CHD.

With a backdrop of American Heart Month, Arnold Meshkov, MD, reflects on the history of cholesterol and advances in the treatment of cholesterol disorders throughout history.

An intervention trial from Germany suggests specialized mobile stroke units could help improve rates of disability and death following a stroke.

In a joint interview, 2 pediatric cardiologists discuss topics related to remote technologies and cardiological monitoring among pediatric populations.

A Stanford Cardiovascular Institute expert details a recent review into managing a growing field of agents.

An analysis of more than 28k incident myocardial infarction events demonstrates increased physical activity levels were associated with a 21-45% lower risk of instant death and a 15-36% lower risk of death in the first 28 days.

Obese individuals were found to have a higher odds ratio of developing IIH compared to non-obese people.

A recent study from Northwestern University suggests 30-53% of all new diabetes cases in the United States were directly attributable to obesity.

A statement from Regeneron announced their ANGPTL3 inhibitor evinacumab (Evkeeza) received approval as an adjunct therapy for lowering LDL-C in patients 12 years and older with homozygous familial hypercholesterolemia.

The indication is the first granted to an ANGPTL3 inhibitor in the US.

Researchers believe identifying more risk factors could be beneficial in reducing cardiovascular disease.

The co-lead investigators discuss the upcoming first study to assess long-term outcomes on MIS-C patients.

An analysis of data from an ethnically diverse cohort of more than 120k patients indicates Chinese adults were more susceptible to obesity-related health complications, such as hypertension, than other racial/ethnic groups.

An analysis of data from the International Consortium of Blood Pressure-Genome Wide Association Studies suggests every 1 mmHg increase in blood pressure was linked to a 1.4-2.6% increase in risk of atrial fibrillation.

Data from an analysis of nearly 400k older patients suggests Medicare Advantage beneficiaries were less likely than their counterparts with commercial insurance to be prescribed newer glucose-lowering agents such as GLP-1RAs and SGLT2 inhibitors.

New data shows that a restrictive blood transfusion strategy resulted in a noninferior rate of major adverse cardiovascular events compared with a more liberal strategy.

An intervention implementing the use of a health coach in a primary care setting based on the 2013 AHA/ACC/Task Force for the Management of Overweight and Obesity in Adults guidelines was associated with greater weight loss and improvements in blood glucose levels and HDL-C compared to usual care.

With studies and editorials being published on the topic at a historic rate, Dr. Paul Thompson offers perspective on what clinicians know about the incidence of COVID-19-related myocarditis in athletes.